Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Breast Adjuvant Escalation

Charles Geyer

MD

🏢University of Pittsburgh Medical Center Hillman Cancer Center🌐USA

Professor of Medicine

85
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Charles Geyer has led major NSABP and NRG Oncology adjuvant breast cancer trials. He was a principal investigator on OlympiA establishing adjuvant olaparib for germline BRCA associated high risk breast cancer. His work has shaped contemporary adjuvant escalation strategies for high risk disease. He is recognized as a leading breast clinical trialist.

Share:

🧪Research Fields 研究领域

breast cancer
adjuvant therapy
HER2 positive
BRCA mutation
clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Charles Geyer 的研究动态

Follow Charles Geyer's research updates

留下邮箱,当我们发布与 Charles Geyer(University of Pittsburgh Medical Center Hillman Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment